Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul-Sep;26(3):382-388.
doi: 10.4103/jomfp.jomfp_293_22. Epub 2022 Oct 17.

Role of Nidogen-2 in diagnosis and prognosis of head and neck squamous cell carcinoma: A systematic review

Tabita Joy Chettiankandy  1 , Sanpreet S Sachdev  1 , Shubhangi P Khandekar  2 , Alka Dive  2 , Deepak Nagpal  3 , Jagdish V Tupkari  1
Affiliations
Review

Role of Nidogen-2 in diagnosis and prognosis of head and neck squamous cell carcinoma: A systematic review

Tabita Joy Chettiankandy et al. J Oral Maxillofac Pathol. 2022 Jul-Sep.

Abstract

Context: Nidogen-2 (NID-2) hypermethylation has been implicated in many types of cancers, such as lung, bladder, and gastric carcinomas. However, its role has not yet been studied adequately in head and neck squamous cell carcinomas (HNSCC). HNSCCs constituting a major portion of the global cancer load, it is of importance to diagnose and treat them at earliest. This systematic review was performed to assess the role of NID-2 in HNSCCs and assess its utility as a diagnostic and prognostic marker.

Materials and methods: A systematic search was performed across multiple databases to identify studies pertaining to analysis of expression or methylation of NID-2 in HNSCCs. The sample size, type of cancer/premalignant condition studied, type of tissue/fluid analysed, and the various methodologies used and their results were extracted. PROSPERO registration number: CRD42021245326.

Results: Four studies were identified after a systematic search of literature. The studies analysed NID-2 expression or methylation in conditions such as nasopharyngeal carcinoma, esophageal carcinoma, and oral squamous cell carcinoma (OSCC). NID-2 was found to be a highly specific marker for HNSCCs, and serum NID-2 levels also correlated with poor survival.

Conclusion: Data from the reviewed studies indicate that hypermethylation of NID-2 is highly specific for HNSCC. The high specificity is maintained in salivary and serum samples, facilitating accurate and non-invasive prognostication of HNSCC. The relatively lower sensitivity of NID-2 methylation may be overcome by analysing it along with a panel of multiple biomarkers such as HOX-A2 and YKL20.

Keywords: Epigenetics; hypermethylation; oral squamous cell carcinoma; salivary biomarkers.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
PRISMA flow chart indicating selection process of articles for final qualitative synthesis of this systematic review
See this image and copyright information in PMC

References

    1. Global Cancer Observatory, India. 2020. [Last accessed on 2021 Sep 26]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/356-india-fact-she... .
    1. Bagan JV, Scully C. Recent advances in oral oncology: Epidemiology, aetiopathogenesis, diagnosis and prognostication. Oral Oncol. 2008;44:103–8. - PubMed
    1. Akbulut N, Oztas B, Kursun S, Evirgen S. Delayed diagnosis of oral squamous cell carcinoma: A case series. J Med Case Rep. 2011;5:1–4. - PMC - PubMed
    1. Ranganathan K, Kavitha L. Oral epithelial dysplasia: Classifications and clinical relevance in risk assessment of oral potentially malignant disorders. J Oral MaxillofacPathol. 2019;23:19–27. - PMC - PubMed
    1. Kim SH, Turnbull J, Guimond S. Extracellular matrix and cell signalling: The dynamic cooperation of integrin, proteoglycan and growth factor receptor. JEndocrinol. 2011;209:139–51. - PubMed